Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma
Experimental Hematology
Saved in:
Main Authors: | O'Neal, J., Gao, F., Hassan, A., Monahan, R., Barrios, S., Lee, I., Chng, W.J., Vij, R., Tomasson, M.H. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2015
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/120865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Investigating status of tumorigenic barriers in monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM)
by: ZAHRA KABIRI
Published: (2010) -
Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
by: Chng, W.-J., et al.
Published: (2014) -
Secondary Burkitt lymphoma in a retinoblastoma patient with 13q deletion syndrome
by: Suradej Hongeng, et al.
Published: (2018) -
Conditional deletion of Cadherin 13 perturbs Golgi cells and disrupts social and cognitive behaviors
by: Tantra, M., et al.
Published: (2020) -
Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress
by: Chu, L., et al.
Published: (2014)